ATRX and cancer: To investigate if this effect on p53 binding is observed in any cancer-derived ALT cells, we assayed U2OS (Supplementary Fig. 5a, b) and GM847 and VA13 (Supplementary Fig. 5c, d), known to have WT p53 protein and an ATRX null background29,30.